Celcuity Inc. – Filings and Transcripts

NASDAQ: CELC
Share price (6/4/26): $92.47
Market cap (6/4/26): $4.509 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of securities for employees

Automatic shelf registration

Ownership Filter

Buller Richard E

Rtw Investments, LP

Buller Richard E

News Filter

Gedatolisib Combination Regimens Doubled the Likelihood of Survival Without Disease Progression or Death Compared to Alpelisib Plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial

Change in Directors, Officers or Compensation

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update

Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Statement of eligibility as a trustee

Scanned paper annual report submission

Statement of eligibility as a trustee

Scanned paper annual report submission

Notice of effectiveness